A new drug being trialled for treating breast cancer and diabetes has been shown to ‘melt away’ the fat inside arteries that can cause heart attacks and strokes.
Researchers from the University of Aberdeen, using pre-clinical mouse models, showed that just a single dose of the drug (Trodusquemine) completely reversed the effects of a disease that causes a host of heart problems.
Atherosclerosis is the build-up of fatty material inside the arteries.
Over time this fatty material can grow bigger until your arteries become so narrow that not enough blood can pass through.
Atherosclerosis is the condition that causes most heart attacks and strokes.
In pre-clinical tests, mice with set-in atherosclerosis, mimicking what happens in humans, had less fatty plaques in their arteries whether they had regular doses over time or just a single dose of Trodusquemine.
The drug works by stopping an enzyme called PTP1B, which is normally increased in people with obesity or diabetes and conditions involving prolonged inflammation such as sepsis, inflamed diabetic foot ulcers and allergic lung inflammation. The researchers found that it also stimulated the action of another protein (AMPK), which effectively mimics exercise and reduces chronic inflammation.
It has already been shown to be effective with diabetes and breast cancer patients but this is the first time the drug has been shown to have benefits for long-term cardiovascular disease.
The £236,000 study was funded by the British Heart Foundation.
Professor Mirela Delibegovic and Dr Dawn Thompson from the University of Aberdeen’s Institute of Medical Sciences who led the study said: “All humans have some level of atherosclerosis. As you age you start to develop these fatty streaks inside your arteries. It is a big problem for people who are overweight or have underlying cardiovascular conditions.”
“Trodusquemine has already been trialled for treatment of diabetes and breast cancer but this is the first time it has been used in models of atherosclerosis.
“These have only been tested at pre-clinical level, in mice, so far but the results were quite impressive and showed that just a single dose of this drug seemed to completely reverse the effects of arthrosclerosis.
“The next step is to test the ability of this drug to improve outcomes in human patients with developed atherosclerosis and cardiovascular disease”.
Learn more: Drug ‘melts away’ fat inside arteries
The Latest on: Atherosclerosis
[google_news title=”” keyword=”atherosclerosis ” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Arsenic in Community Water Raises Type 2 Diabetes Riskon May 9, 2024 at 4:59 pm
This study relied on two cohorts — the Strong Heart Family Study (SHFS) and the Multi-Ethnic Study of Atherosclerosis (MESA) — to elucidate the prospective association between T2D and arsenic levels ...
- Atherosclerosis Progression May Share Traits With Tumor Growthon May 7, 2024 at 5:00 pm
The progression of atherosclerosis, at a cellular level, is reminiscent of the processes involved in tumor growth, new research confirms. Importantly, the idea itself is not new—but until now, the ...
- Vietnam Atherosclerosis Drugs Market Plotting the Course Audience Odyssey and Target Market Strategyon May 7, 2024 at 12:54 am
This country research report on Vietnam Atherosclerosis Drugs Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam market.
- Clogged arteries worsened by cells that behave like cancer cellson May 1, 2024 at 5:35 pm
Researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment.
- New study reveals cancer-like features in atherosclerosison April 30, 2024 at 11:22 am
LOS ANGELES, April 30 (Xinhua) -- U.S. researchers have discovered that the smooth muscle cells that line the arteries of people with atherosclerosis can change into new cell types and develop traits ...
- Scientists find cancer-like features in atherosclerosis, spurring opportunity for new treatment approacheson April 30, 2024 at 6:18 am
Researchers have discovered that the smooth muscle cells that line the arteries of people with atherosclerosis can change into new cell types and develop traits similar to cancer that worsen the ...
- Highlights in Atherosclerosis and Lipid Management From ACC 2024on April 29, 2024 at 2:07 pm
Lipid highlights from ACC 2024 included positive outcomes for bempedoic acid in statin-intolerant patients and for an inclisiran-first strategy in those with atherosclerosis.
- Abatacept may decelerate progression of atherosclerosis in RA patients with CVD: Studyon April 28, 2024 at 8:00 pm
Researchers have found that abatacept treatment may benefit patients with rheumatoid arthritis (RA) who have a high risk of cardiovascular disease, according to a study published in ...
- What Is Atherosclerosis?on April 10, 2024 at 5:00 pm
Atherosclerosis is a narrowing of the arteries caused by a buildup of cholesterol plaque. It may lead to stroke, heart attacks, dementia, and other health challenges. When plaque builds up and the ...
- Physical fitness in male adolescents and atherosclerosis in middle age: a population-based cohort studyon February 14, 2024 at 2:10 pm
Objectives To examine the associations between physical fitness in male adolescents and coronary and carotid atherosclerosis in middle age. Methods This population-based cohort study linked physical ...
via Google News and Bing News